Modulation of operational lung volumes with the use of salbutamol in COPD patients accomplishing upper limbs exercise tests

Detalhes bibliográficos
Autor(a) principal: Porto, Elias Ferreira [UNIFESP]
Data de Publicação: 2009
Outros Autores: Castro, Antônio Adolfo Mattos de [UNIFESP], Nascimento, Oliver Augusto [UNIFESP], Oliveira, Rosangela C. [UNIFESP], Cardoso, Fábio [UNIFESP], Jardim, José Roberto [UNIFESP]
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: http://dx.doi.org/10.1016/j.rmed.2008.08.018
http://repositorio.unifesp.br/handle/11600/31264
Resumo: Introduction: Pulmonary dynamic hyperinflation (DH) is an important factor limiting the physical capacity of patients with COPD. Inhaled bronchodilator should be able to reduce DH.Objective: To measure DH in COPD patients during upper limbs exercise tests with previous use of bronchodilator or placebo, and to evaluate the respiratory pattern to justify the dynamics of hyperinflation.Methods: Inspiratory capacity (IC) of 16 patients with COPD (age: 63 13 years; FEV(1) of 1.5 +/- 0.7 L-41 +/- 11% predicted) was measured before and after an incremental arm exercise test (diagonal technique) with randomly and double-blinded inhaled placebo or salbutamol. Results: Rest IC increased from 2.32 +/- 0.44 L to 2.54 +/- 0.39 L after inhalation of 400 mcg of salbutamol. (p = 0.0012). There was a decrease in the IC after a maximal incremental arm exercise test, 222 +/- 158 ml. (p = 0.001) with placebo use, but no change was seen after the salbutamol use: 104 +/- 205 ml (p = 0.41); 62% of the patients presented a 10% or more reduction in the IC after the exercise with placebo. There was a correlation between DH and lower FEV(1)/FVC (p = 0.0067), FEV, predicted (p = 0.0091) and IC% predicted (p = 0.043) and higher VO(2) ml/Kg/min % predicted (p = 0.05). Minute ventilation and respiratory rate were higher during the exercise with placebo (p = 0.002) whereas VE/MVV ratio was tower in the exercise after salbutamol (p > 0.05).Conclusion: We conclude that the use of bronchodilator increases the IC of patient with COPD and may help not to increase the DH during a maximal. exercise with the arms. (C) 2008 Elsevier B.V. All rights reserved.
id UFSP_518db93698482cb22784afaeb6f185fc
oai_identifier_str oai:repositorio.unifesp.br/:11600/31264
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Modulation of operational lung volumes with the use of salbutamol in COPD patients accomplishing upper limbs exercise testsUpper limbs exerciseDynamic hyperinflationSalbutamolCOPDIntroduction: Pulmonary dynamic hyperinflation (DH) is an important factor limiting the physical capacity of patients with COPD. Inhaled bronchodilator should be able to reduce DH.Objective: To measure DH in COPD patients during upper limbs exercise tests with previous use of bronchodilator or placebo, and to evaluate the respiratory pattern to justify the dynamics of hyperinflation.Methods: Inspiratory capacity (IC) of 16 patients with COPD (age: 63 13 years; FEV(1) of 1.5 +/- 0.7 L-41 +/- 11% predicted) was measured before and after an incremental arm exercise test (diagonal technique) with randomly and double-blinded inhaled placebo or salbutamol. Results: Rest IC increased from 2.32 +/- 0.44 L to 2.54 +/- 0.39 L after inhalation of 400 mcg of salbutamol. (p = 0.0012). There was a decrease in the IC after a maximal incremental arm exercise test, 222 +/- 158 ml. (p = 0.001) with placebo use, but no change was seen after the salbutamol use: 104 +/- 205 ml (p = 0.41); 62% of the patients presented a 10% or more reduction in the IC after the exercise with placebo. There was a correlation between DH and lower FEV(1)/FVC (p = 0.0067), FEV, predicted (p = 0.0091) and IC% predicted (p = 0.043) and higher VO(2) ml/Kg/min % predicted (p = 0.05). Minute ventilation and respiratory rate were higher during the exercise with placebo (p = 0.002) whereas VE/MVV ratio was tower in the exercise after salbutamol (p > 0.05).Conclusion: We conclude that the use of bronchodilator increases the IC of patient with COPD and may help not to increase the DH during a maximal. exercise with the arms. (C) 2008 Elsevier B.V. All rights reserved.Universidade Federal de São Paulo, Pulm Rehabil Ctr, BR-04023062 São Paulo, BrazilAdventist Univ, São Paulo, BrazilUniv Guarulhos, São Paulo, BrazilUniversidade Federal de São Paulo, Pulm Rehabil Ctr, BR-04023062 São Paulo, BrazilWeb of ScienceW B Saunders Co LtdUniversidade Federal de São Paulo (UNIFESP)Adventist UnivUniv GuarulhosPorto, Elias Ferreira [UNIFESP]Castro, Antônio Adolfo Mattos de [UNIFESP]Nascimento, Oliver Augusto [UNIFESP]Oliveira, Rosangela C. [UNIFESP]Cardoso, Fábio [UNIFESP]Jardim, José Roberto [UNIFESP]2016-01-24T13:52:12Z2016-01-24T13:52:12Z2009-02-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion251-257application/pdfhttp://dx.doi.org/10.1016/j.rmed.2008.08.018Respiratory Medicine. London: W B Saunders Co Ltd, v. 103, n. 2, p. 251-257, 2009.10.1016/j.rmed.2008.08.018WOS000263187100014.pdf0954-6111http://repositorio.unifesp.br/handle/11600/31264WOS:000263187100014engRespiratory Medicineinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-07-31T05:22:20Zoai:repositorio.unifesp.br/:11600/31264Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-07-31T05:22:20Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.none.fl_str_mv Modulation of operational lung volumes with the use of salbutamol in COPD patients accomplishing upper limbs exercise tests
title Modulation of operational lung volumes with the use of salbutamol in COPD patients accomplishing upper limbs exercise tests
spellingShingle Modulation of operational lung volumes with the use of salbutamol in COPD patients accomplishing upper limbs exercise tests
Porto, Elias Ferreira [UNIFESP]
Upper limbs exercise
Dynamic hyperinflation
Salbutamol
COPD
title_short Modulation of operational lung volumes with the use of salbutamol in COPD patients accomplishing upper limbs exercise tests
title_full Modulation of operational lung volumes with the use of salbutamol in COPD patients accomplishing upper limbs exercise tests
title_fullStr Modulation of operational lung volumes with the use of salbutamol in COPD patients accomplishing upper limbs exercise tests
title_full_unstemmed Modulation of operational lung volumes with the use of salbutamol in COPD patients accomplishing upper limbs exercise tests
title_sort Modulation of operational lung volumes with the use of salbutamol in COPD patients accomplishing upper limbs exercise tests
author Porto, Elias Ferreira [UNIFESP]
author_facet Porto, Elias Ferreira [UNIFESP]
Castro, Antônio Adolfo Mattos de [UNIFESP]
Nascimento, Oliver Augusto [UNIFESP]
Oliveira, Rosangela C. [UNIFESP]
Cardoso, Fábio [UNIFESP]
Jardim, José Roberto [UNIFESP]
author_role author
author2 Castro, Antônio Adolfo Mattos de [UNIFESP]
Nascimento, Oliver Augusto [UNIFESP]
Oliveira, Rosangela C. [UNIFESP]
Cardoso, Fábio [UNIFESP]
Jardim, José Roberto [UNIFESP]
author2_role author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade Federal de São Paulo (UNIFESP)
Adventist Univ
Univ Guarulhos
dc.contributor.author.fl_str_mv Porto, Elias Ferreira [UNIFESP]
Castro, Antônio Adolfo Mattos de [UNIFESP]
Nascimento, Oliver Augusto [UNIFESP]
Oliveira, Rosangela C. [UNIFESP]
Cardoso, Fábio [UNIFESP]
Jardim, José Roberto [UNIFESP]
dc.subject.por.fl_str_mv Upper limbs exercise
Dynamic hyperinflation
Salbutamol
COPD
topic Upper limbs exercise
Dynamic hyperinflation
Salbutamol
COPD
description Introduction: Pulmonary dynamic hyperinflation (DH) is an important factor limiting the physical capacity of patients with COPD. Inhaled bronchodilator should be able to reduce DH.Objective: To measure DH in COPD patients during upper limbs exercise tests with previous use of bronchodilator or placebo, and to evaluate the respiratory pattern to justify the dynamics of hyperinflation.Methods: Inspiratory capacity (IC) of 16 patients with COPD (age: 63 13 years; FEV(1) of 1.5 +/- 0.7 L-41 +/- 11% predicted) was measured before and after an incremental arm exercise test (diagonal technique) with randomly and double-blinded inhaled placebo or salbutamol. Results: Rest IC increased from 2.32 +/- 0.44 L to 2.54 +/- 0.39 L after inhalation of 400 mcg of salbutamol. (p = 0.0012). There was a decrease in the IC after a maximal incremental arm exercise test, 222 +/- 158 ml. (p = 0.001) with placebo use, but no change was seen after the salbutamol use: 104 +/- 205 ml (p = 0.41); 62% of the patients presented a 10% or more reduction in the IC after the exercise with placebo. There was a correlation between DH and lower FEV(1)/FVC (p = 0.0067), FEV, predicted (p = 0.0091) and IC% predicted (p = 0.043) and higher VO(2) ml/Kg/min % predicted (p = 0.05). Minute ventilation and respiratory rate were higher during the exercise with placebo (p = 0.002) whereas VE/MVV ratio was tower in the exercise after salbutamol (p > 0.05).Conclusion: We conclude that the use of bronchodilator increases the IC of patient with COPD and may help not to increase the DH during a maximal. exercise with the arms. (C) 2008 Elsevier B.V. All rights reserved.
publishDate 2009
dc.date.none.fl_str_mv 2009-02-01
2016-01-24T13:52:12Z
2016-01-24T13:52:12Z
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1016/j.rmed.2008.08.018
Respiratory Medicine. London: W B Saunders Co Ltd, v. 103, n. 2, p. 251-257, 2009.
10.1016/j.rmed.2008.08.018
WOS000263187100014.pdf
0954-6111
http://repositorio.unifesp.br/handle/11600/31264
WOS:000263187100014
url http://dx.doi.org/10.1016/j.rmed.2008.08.018
http://repositorio.unifesp.br/handle/11600/31264
identifier_str_mv Respiratory Medicine. London: W B Saunders Co Ltd, v. 103, n. 2, p. 251-257, 2009.
10.1016/j.rmed.2008.08.018
WOS000263187100014.pdf
0954-6111
WOS:000263187100014
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Respiratory Medicine
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 251-257
application/pdf
dc.publisher.none.fl_str_mv W B Saunders Co Ltd
publisher.none.fl_str_mv W B Saunders Co Ltd
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv biblioteca.csp@unifesp.br
_version_ 1814268379791360000